Clincosm LogoSign in Get a demo

Effect of Cholesterol Level on Postoperative Acute Kidney Injury of Non-cardiac Surgeries

Sponsor
Peking University First Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03954353
Collaborator
(none)
78,888
Enrollment
1
Location
20
Actual Duration (Days)
120057.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Preoperative serum cholesterol level may influence occurrence of postoperative acute kidney injury of cardiac surgeries. However, the effect of Preoperative serum cholesterol level for non cardiac surgery remains unknown. This study aimed to explore the effect in non-cardiac surgical population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    78888 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Effect of Cholesterol Level on Postoperative Acute Kidney Injury of Non-cardiac Surgeries
    Actual Study Start Date :
    May 17, 2019
    Actual Primary Completion Date :
    Jun 5, 2019
    Actual Study Completion Date :
    Jun 6, 2019

    Outcome Measures

    Primary Outcome Measures

    1. post-operative acute kidney injury within 30 days in the hospital [30 days postoperatively in hospital]

      It was defined by patient's postoperative serum creatine increase no less than 26.5 μmol/l within 48 hours, or 1.5 times from baseline within the 7 days after surgery or initializing blood dialysis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    adults elective non-cardiac surgery

    Exclusion Criteria:

    cardiac surgeries kidney surgeries obstetric surgeries local infiltration anesthesia perioperative data missing

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 First hospital Peking University Beijing Beijing China 100034

    Sponsors and Collaborators

    • Peking University First Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yan Zhou, MD, Principal Investigator, Peking University First Hospital
    ClinicalTrials.gov Identifier:
    NCT03954353
    Other Study ID Numbers:
    • ECAKI
    First Posted:
    May 17, 2019
    Last Update Posted:
    Jul 9, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Acute Kidney Injury
    Wounds and Injuries

    Study Results

    No Results Posted as of Jul 9, 2019